Low impact
Eli Lilly received FDA clearance for an oral GLP-1 drug targeting over one billion potential patients worldwide.
Finnhub07/25, 12:30 AM
- one billion
Figures as quoted by Finnhub
Related assets
Coming up for LLY
Explore next
Latest LLY news
Jin1008/17, 07:48 PM
Bloomberg08/13, 05:57 PM
FirstSquawk08/13, 12:08 PM
Berenberg raises Eli Lilly price target to $1,220 from $1,135.